AGP Picks
View all

Today in the News
Provided by AGP

Today in the News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 8, 2026

MIMEDX to Participate in Upcoming Investor Conferences
Sep. 8, 2026

MIMEDX to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
FTC Solar Begins Shipments on 330 MW Fraser Coast Project in Australia
Sep. 8, 2026

FTC Solar Begins Shipments on 330 MW Fraser Coast Project in Australia

Indeterminate GlobeNewswire
Enphase Advances IQ Solid-State Transformer Development for AI Data Centers with Power Modules Now Being Built in Texas
Sep. 8, 2026

Enphase Advances IQ Solid-State Transformer Development for AI Data Centers with Power Modules Now Being Built in Texas

Indeterminate GlobeNewswire
Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management
Sep. 8, 2026

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire
Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026
Sep. 8, 2026

Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026

Indeterminate GlobeNewswire
BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema
Sep. 8, 2026

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire
NowVertical Expands Google Cloud Practice into Brazil
Sep. 8, 2026

NowVertical Expands Google Cloud Practice into Brazil

Indeterminate GlobeNewswire
Longevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross Proceeds
Sep. 8, 2026

Longevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross Proceeds

Indeterminate GlobeNewswire
International Land Alliance Adds Scalable AI Agentic Solution for Lead Generation
Sep. 8, 2026

International Land Alliance Adds Scalable AI Agentic Solution for Lead Generation

Indeterminate GlobeNewswire
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Sep. 8, 2026

Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep. 8, 2026

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Liberty Global Agrees to Sell Dutch Towers Ahead of 2027 Ziggo Group Listing
Sep. 8, 2026

Liberty Global Agrees to Sell Dutch Towers Ahead of 2027 Ziggo Group Listing

Indeterminate GlobeNewswire
Top pension funds grow at fastest rate since 2017
Sep. 8, 2026

Top pension funds grow at fastest rate since 2017

Indeterminate GlobeNewswire
Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3
Sep. 8, 2026

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire
DotKonnekt Expands Kompass Studio to Give Enterprises AI Sovereignty
Sep. 8, 2026

DotKonnekt Expands Kompass Studio to Give Enterprises AI Sovereignty

Indeterminate GlobeNewswire
SimPure Back-to-School Sale: Plug-and-Use Water Filtration Designed for Student Life
Sep. 8, 2026

SimPure Back-to-School Sale: Plug-and-Use Water Filtration Designed for Student Life

Indeterminate GlobeNewswire
Dynamic Creatures Emerges from Stealth to Launch New Category of Mobile, Interactive Character Robots for Hospitality and Entertainment
Sep. 8, 2026

Dynamic Creatures Emerges from Stealth to Launch New Category of Mobile, Interactive Character Robots for Hospitality and Entertainment

Indeterminate GlobeNewswire
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings
Sep. 8, 2026

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings

Indeterminate GlobeNewswire
WEEX returns to TOKEN2049 Singapore as platinum sponsor, as trading moves beyond crypto
Sep. 8, 2026

WEEX returns to TOKEN2049 Singapore as platinum sponsor, as trading moves beyond crypto

Indeterminate GlobeNewswire
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
Sep. 8, 2026

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in the News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.